183 related articles for article (PubMed ID: 28887510)
1. MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis.
Liu Y; Wang M; Luo Y; Chen J; Lu Y; Shi Y; Tang C; Zhou Q; Zhang H; Hu Y; Su S; Chen Q
Sci Rep; 2017 Sep; 7(1):11054. PubMed ID: 28887510
[TBL] [Abstract][Full Text] [Related]
2. Study of ZHENG differentiation in hepatitis B-caused cirrhosis: a transcriptional profiling analysis.
Lu YY; Chen QL; Guan Y; Guo ZZ; Zhang H; Zhang W; Hu YY; Su SB
BMC Complement Altern Med; 2014 Oct; 14():371. PubMed ID: 25280538
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis.
Chen Q; Wu F; Wang M; Dong S; Liu Y; Lu Y; Song Y; Zhou Q; Liu P; Luo Y; Su S
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271613
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of Same TCM Syndrome for Different Diseases and Different TCM Syndrome for Same Disease in Chronic Hepatitis B and Liver Cirrhosis.
Guo Z; Yu S; Guan Y; Li YY; Lu YY; Zhang H; Su SB
Evid Based Complement Alternat Med; 2012; 2012():120350. PubMed ID: 22693527
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis B: dynamic change in Traditional Chinese Medicine syndrome by dynamic network biomarkers.
Lu Y; Fang Z; Zeng T; Li M; Chen Q; Zhang H; Zhou Q; Hu Y; Chen L; Su S
Chin Med; 2019; 14():52. PubMed ID: 31768187
[TBL] [Abstract][Full Text] [Related]
6. Biological differentiation of traditional Chinese medicine from excessive to deficient syndromes in AIDS: Comparative microRNA microarray profiling and syndrome-specific biomarker identification.
Wan T; Liu X; Su Y; Zou J; Wu X; Jiang C; Cao C; Yao M; Zhou Y; Rong L; Li B; Wen L; Feng Q
J Med Virol; 2021 Jun; 93(6):3634-3646. PubMed ID: 33289096
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B.
Zhang H; Guan Y; Lu YY; Hu YY; Huang S; Su SB
Evid Based Complement Alternat Med; 2013; 2013():751341. PubMed ID: 23554832
[TBL] [Abstract][Full Text] [Related]
8. A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes.
Song YN; Chen J; Cai FF; Lu YY; Chen QL; Zhang YY; Liu P; Su SB
Acta Pharmacol Sin; 2018 Jun; 39(6):942-951. PubMed ID: 29072258
[TBL] [Abstract][Full Text] [Related]
9. Global microRNA expression profiling in the liver biopsies of hepatitis B virus-infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury.
Singh AK; Rooge SB; Varshney A; Vasudevan M; Bhardwaj A; Venugopal SK; Trehanpati N; Kumar M; Geffers R; Kumar V; Sarin SK
Hepatology; 2018 May; 67(5):1695-1709. PubMed ID: 29194684
[TBL] [Abstract][Full Text] [Related]
10. Comparative serum microRNA array analysis of the spleen-stomach dampness-heat syndrome in different diseases: Chronic hepatitis B and chronic gastritis.
Li B; Su Y; Xiang N; Qin B; Li G; Wan T; Liu X; Wang D; Jiang C; Wen L; Feng QS
Anat Rec (Hoboken); 2021 Nov; 304(11):2620-2631. PubMed ID: 34288535
[TBL] [Abstract][Full Text] [Related]
11. Biological Differentiation of Dampness-Heat Syndromes in Chronic Hepatitis B: From Comparative MicroRNA Microarray Profiling to Biomarker Identification.
Wen L; Jiang C; Wan TJ; Wang D; Yan D; Li GY; Su Y; Liu XY; Rong LJ; Ye H; Li BX; Feng QS
Evid Based Complement Alternat Med; 2020; 2020():7234893. PubMed ID: 32051688
[TBL] [Abstract][Full Text] [Related]
12. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846
[TBL] [Abstract][Full Text] [Related]
13. Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT.
Cheng JL; Zhao H; Yang SG; Chen EM; Chen WQ; Li LJ
Hepatol Int; 2018 May; 12(3):277-287. PubMed ID: 29881991
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
15. Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes.
Shi MJ; Xiao HM; Xie YB; Jiang JM; Zhao PT; Cai GS; Li YX; Li S; Zhang CZ; Cao ML; Chen QB; Tan ZJ; Gao HJ; Chi XL
Evid Based Complement Alternat Med; 2020; 2020():5956940. PubMed ID: 33178319
[TBL] [Abstract][Full Text] [Related]
16. Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers.
Ninomiya M; Kondo Y; Funayama R; Nagashima T; Kogure T; Kakazu E; Kimura O; Ueno Y; Nakayama K; Shimosegawa T
PLoS One; 2013; 8(6):e66086. PubMed ID: 23776611
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
18. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical characteristics of traditional Chinese medicine syndromes and their elements in patients with hepatitis B cirrhosis].
Yuan JL; Zhang H; Wang L; Lin Y; Hu XC; Zhang Q; Liu P
Zhong Xi Yi Jie He Xue Bao; 2011 Apr; 9(4):374-81. PubMed ID: 21486549
[TBL] [Abstract][Full Text] [Related]
20. [Investigation on traditional Chinese medicine syndrome distribution of 4 618 hepatitis B virus infection subjects in Qidong of Jiangsu Province, China].
Lang QB; Zhai DX; Huang F; Chen JG; Zhang YH; Liu Q; Zhai XF; Li B; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 May; 10(5):525-31. PubMed ID: 22587974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
